Syndax Pharmaceuticals Inc (SNDX) stock
SNDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.45−0.09 (-0.94%)
Close on Nov 13, 2026Market cap $843.86MP/E –Yield –
Syndax Pharmaceuticals ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2019 | Sep 30, 2019 | -$13.33M | – |
| Q2 FY2019 | Jun 30, 2019 | -$15.60M | – |
| Q1 FY2019 | Mar 31, 2019 | -$14.99M | – |
| Q3 FY2018 | Sep 30, 2018 | -$17.99M | – |
| Q2 FY2018 | Jun 30, 2018 | -$19.03M | – |
| Q1 FY2018 | Mar 31, 2018 | -$19.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$15.29M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$13.17M | – |
See a number that looks wrong?